| Scorecard |
|---|
|
---
|
|
Lipper
---
|
|
Zacks Investment Research
---
|
|
Standard & Poor's
---
|
|
TheStreet.com
---
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.0 | 0.0 |
| Stocks | 100.0 | 100.0 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 0.0 | 0.0 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 12.31.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 12.31.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Medidata Solutions, Inc. | MDSO | 69.09 | 5.46 |
| ACADIA Pharmaceuticals, Inc. | ACAD | 158.49 | 5.19 |
| NPS Pharmaceuticals Inc | NPSP | 42.86 | 5.08 |
| Incyte Corp Ltd | INCY | 29.56 | 4.63 |
| Supernus Pharmaceuticals Inc | SUPN | -30.4 | 4.0 |
| Dyax Corporation | DYAX | -23.28 | 3.88 |
| Illumina, Inc. | ILMN | 14.8 | 3.88 |
| DexCom, Inc. | DXCM | 24.36 | 3.8 |
| Coronado Biosciences Inc | CNDO | 137.47 | 3.77 |
| Synta Pharmaceuticals, Inc. | SNTA | 13.64 | 3.77 |
